1. Home
  2. ALIT vs INDP Comparison

ALIT vs INDP Comparison

Compare ALIT & INDP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Alight Inc.

ALIT

Alight Inc.

HOLD

Current Price

$11.93

Market Cap

394.4M

ML Signal

HOLD

Logo Indaptus Therapeutics Inc.

INDP

Indaptus Therapeutics Inc.

HOLD

Current Price

$3.50

Market Cap

438.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ALIT
INDP
Founded
2017
2000
Country
United States
United States
Employees
N/A
N/A
Industry
Business Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
394.4M
438.4M
IPO Year
2020
2021

Fundamental Metrics

Financial Performance
Metric
ALIT
INDP
Price
$11.93
$3.50
Analyst Decision
Hold
Analyst Count
5
0
Target Price
★ $16.33
N/A
AVG Volume (30 Days)
★ 686.8K
329.8K
Earning Date
11-03-2026
11-20-2026
Dividend Yield
★ 6.24%
N/A
EPS Growth
N/A
★ N/A
EPS
N/A
★ N/A
Revenue
★ $2,262,000,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
★ N/A
52 Week Low
$0.48
$0.92
52 Week High
$23.68
$5.96

Technical Indicators

Market Signals
Indicator
ALIT
INDP
Relative Strength Index (RSI) 68.27 56.14
Support Level $8.20 $2.05
Resistance Level $13.21 $3.84
Average True Range (ATR) 1.08 0.31
MACD 0.44 0.02
Stochastic Oscillator 54.46 78.10

Price Performance

Historical Comparison
ALIT
INDP

About ALIT Alight Inc.

Alight Inc is a technology-enabled services company delivering human capital management solutions to many complex organizations. This includes the implementation and administration of employee benefits (e.g., health, wealth, and leave benefits) solutions, which currently operate under one reportable segment, Employer Solutions. The Employer Solutions segment is driven by the Alight Worklife platform, and includes integrated benefits administration, healthcare navigation, financial well-being, leave of absence management, and retiree healthcare. Geographically, the company generates the majority of its revenue from the United States.

About INDP Indaptus Therapeutics Inc.

Indaptus Therapeutics Inc is a clinical biotechnology company that has developed a novel and patented systemically-administered anti-cancer and anti-viral immunotherapy. Its approach is based on the hypothesis that efficient activation of both innate and adaptive immune cells and associated anti-tumor and anti-viral immune responses will require a multi-targeted package of immune system activating signals that can be administered safely intravenously. Its patented technology is composed of single strains of attenuated and killed, non-pathogenic, Gram-negative bacteria, designed to have reduced i.v. toxicity, but largely uncompromised ability to prime or activate many of the cellular components of innate and adaptive immunity. Its candidate, Decoy20 is for patients with solid tumors.

Share on Social Networks: